home / stock / atrc / atrc news


ATRC News and Press, AtriCure Inc. From 07/30/19

Stock Information

Company Name: AtriCure Inc.
Stock Symbol: ATRC
Market: NASDAQ
Website: atricure.com

Menu

ATRC ATRC Quote ATRC Short ATRC News ATRC Articles ATRC Message Board
Get ATRC Alerts

News, Short Squeeze, Breakout and More Instantly...

ATRC - AtriCure, Inc. (ATRC) CEO Mike Carrel on Q2 2019 Results - Earnings Call Transcript

AtriCure, Inc. (ATRC) Q2 2019 Results Conference Call July 30, 2019 04:30 PM ET Company Participants Lynn Lewis - Gilmartin Group Mike Carrel - President and Chief Executive Officer Andy Wade - Senior Vice President and Chief Financial Officer Conference Call Participants C...

ATRC - AtriCure EPS in-line, beats on revenue

AtriCure (NASDAQ: ATRC ): Q2 Non-GAAP EPS of -$0.17 in-line; GAAP EPS of -$0.11 beats by $0.06 . More news on: AtriCure, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...

ATRC - AtriCure Reports Second Quarter 2019 Financial Results

Worldwide revenue of $58.9 million – an increase of 13.7% year over year U.S. revenue of $47.2 million – an increase of 15.5% year over year International revenue of $11.7 million – an increase of 7.0% year over year AtriCure, Inc. ( Nasdaq: ATRC ),...

ATRC - Notable earnings after Tuesday's close

AAPL , ACHC , ADSW , AKAM , ALL , AMD , AMGN , APAM , ARCB , ASH , ATEN , ATRC , AX , AXS , BEAT , BLKB , BXP , BYD , CACC , CDAY , CHRW , CINF , CNO , COHR , CRY , CSLT , DENN , DLR , EA , EGHT , ENPH , EQR , EXP , EXR , FCPT , FEYE , FMC , GILD , GNW...

ATRC - AtriCure to Participate at the Canaccord Genuity 39th Annual Growth Conference

AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in surgical treatments for atrial fibrillation (Afib) and left atrial appendage management, today announced that the company will be participating in the upcoming Canaccord Genuity 39 th Annual Growth Conference in Boston. AtriCure&#...

ATRC - AtriCure to Announce Second Quarter 2019 Financial Results

AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that it will release its second quarter 2019 financial results on Tuesday, July 30, 2019. AtriCure will host a conference call at...

ATRC - FOMO Rally Part Deux - Charting Goldman Sachs

I introduced the idea that "Fear Of Missing Out" driven trade was afoot this past Friday and got in depth in my Sunday piece. You might want to start with the Sunday piece first to get the most out of this note. We are in a "Goldilocks" moment, let's embrace it, even if it goes against our...

ATRC - FOMO Rally Part Deux - Charting Goldman Sachs

I introduced the idea that "Fear Of Missing Out" driven trade was afoot this past Friday and got in depth in my Sunday piece. You might want to start with the Sunday piece first to get the most out of this note. We are in a "Goldilocks" moment, let's embrace it, even if it goes against our...

ATRC - The Worst Of Times Is The Best Of Times To Buy Stocks

I Hope You Started Buying Yesterday I've said this before but like a lot of what I do, it bears repeating. Stocks are the only item that loses attractiveness when the prices go down. Most people wait for a sale or they go to a discount store because they hate paying more for something if the...

ATRC - AtriCure's (ATRC) CEO Mike Carrel on Q1 2019 Results - Earnings Call Transcript

AtriCure (ATRC) Q1 2019 Earnings Conference Call April 25, 2019 04:30 PM ET Company Participants Lynn Lewis - Investor Relations, Gilmartin Group Mike Carrel - President and Chief Executive Officer Andy Wade - Senior Vice President and Chief Financial Officer Conference Call P...

Previous 10 Next 10